Double Swords 双剑论股
双剑独门指标 ALL In ONE Indicator: 筹码主力线,牛熊指标,6均线. [中文字幕]
Double Swords 双剑论股
Publish date: Fri, 23 Aug 2024, 01:40 PM
Double Swords 双剑论股
0 4,206
Double Swords 双剑论股 https://www.youtube.com/channel/UCfBCbkqZM8xLGjvN-ucIbeQ
双剑合璧KLSE吹水站
https://t.me/joinchat/wsTteKWMlw5kN2Y1
基本面技术面双剑合璧
https://www.facebook.com/groups/203715566878990/
Old Friends Investing
http://oldfriendsinvesting.blogspot.com/
Tradingview Volume Profile indicators 筹码峰
https://www.tradingview.com/gopro/?share_your_love=wongpingloong
双剑合璧KLSE吹水站
https://t.me/joinchat/wsTteKWMlw5kN2Y1
基本面技术面双剑合璧
https://www.facebook.com/groups/203715566878990/
Old Friends Investing
http://oldfriendsinvesting.blogspot.com/
Tradingview Volume Profile indicators 筹码峰
https://www.tradingview.com/gopro/?share_your_love=wongpingloong
双剑独门指标 ALL In ONE Indicator: 筹码主力线,牛熊指标,6均线. [中文字幕]
https://youtu.be/XNOkEyalEiE
双剑独门指标 ALL In ONE Indicator: 筹码主力线,牛熊指标,6均线. [中文字幕]
More articles on Double Swords 双剑论股
PCHEM PETRONAS CHEMICAL 机会來了. 止跌回升弹上去,回调买上涨! [CC 中英文字幕 ENG SUB]
Created by Double Swords 双剑论股 | Aug 25, 2024
TENAGA TNB 国家能源 上升趋势转成盘头,如果再跌破筹码峰是卖出讯号. [CC 中英文字幕 ENG SUB]
Created by Double Swords 双剑论股 | Aug 24, 2024
GENETEC 今早大跌,可以去接刀吗？独家分享如何确认止跌回升弹上去的讯号![CC 中英文字幕 ENG SUB]
Created by Double Swords 双剑论股 | Aug 23, 2024
99 Speedmart IPO 上市. PE 高达35X. 招股书全面分析.预测未来3年的盈利与 forwarded PE. [中文字幕]
Created by Double Swords 双剑论股 | Aug 21, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
.png)
Apps
Top Articles
1
Mercury Securities Research
3
4
save malaysia!
5
BFM Podcast
7
BFM Podcast
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
No trading signals available.
Stock
Time
Signal
Duration
No trading signals available.
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
